SIBIONICS и PharmaSens исследуют новые горизонты для автоматической доставки инсулина на EASD 2026

ConferenceinsulinPositive

AI Analysis

Summary

SiBionics and PharmaSens presented research on automated insulin delivery at EASD 2026 conference, introducing a program connecting continuous monitoring with future diabetes treatment approaches.

Importance:4/10

Sentiment:

0.50

diabetesinsulin deliveryautomated treatmentcontinuous monitoringEASD 2026

Read the original article

Published by PR Newswire Biotech on October 4, 2026 9:16 PM

Read Original